CNR1 and glioblastoma: The involvement of CB2 but not CB1 in CBD-triggered effects was demonstrated in several models: the inhibition of proliferation and viability in murine thymoma and human leukemic cells [31] and human glioblastoma [12] and PARP cleavage in prostate carcinoma [27].